Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.
作者信息
Kanate Abraham S, DiGilio Alyssa, Ahn Kwang W, Al Malki Monzr, Jacobsen Eric, Steinberg Amir, Hamerschlak Nelson, Kharfan-Dabaja Mohamed, Salit Rachel, Ball Edward, Bashir Qaiser, Cashen Amanda, Couriel Daniel, Diez-Martin Jose, Katsanis Emmanuel, Linhares Yulia, Mori Shahram, Nash Richard, Pawarode Attaphol, Perales Miguel-Angel, Phipps Colin D, Richman Carol, Savani Bipin N, Shapira Michael Y, Stiff Patrick, Strair Roger, Fenske Timothy S, Smith Sonali M, Sureda Anna, Olteanu Horatiu, Hamadani Mehdi
机构信息
Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, WV, USA.
CIBMTR (Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
出版信息
Br J Haematol. 2018 Sep;182(6):916-920. doi: 10.1111/bjh.14879. Epub 2017 Aug 2.
Abstract
摘要
相似文献
1
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.
Br J Haematol. 2018 Sep;182(6):916-920. doi: 10.1111/bjh.14879. Epub 2017 Aug 2.
2
Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.
Int J Hematol. 2018 Jan;107(1):98-104. doi: 10.1007/s12185-017-2324-z. Epub 2017 Aug 30.
3
Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
J Med Case Rep. 2020 Mar 17;14(1):43. doi: 10.1186/s13256-020-02363-3.
4
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Am J Hematol. 2021 Jul 1;96(7):834-845. doi: 10.1002/ajh.26200. Epub 2021 May 3.
5
Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma.
Cancer Res Treat. 2017 Jan;49(1):92-103. doi: 10.4143/crt.2015.476. Epub 2016 May 9.
6
[Clinical study of extranodal NK-T cell lymphoma-nasal type].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2005 Nov;40(11):850-4.
7
[Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
Orv Hetil. 2017 Oct;158(41):1635-1641. doi: 10.1556/650.2017.30871.
8
Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT.
Bone Marrow Transplant. 2011 Sep;46(9):1270-1. doi: 10.1038/bmt.2010.284. Epub 2010 Nov 8.
9
Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type.
Leuk Lymphoma. 2011 Jul;52(7):1255-61. doi: 10.3109/10428194.2011.572322. Epub 2011 May 23.
10
Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
Br J Haematol. 2009 Oct;147(1):13-21. doi: 10.1111/j.1365-2141.2009.07802.x. Epub 2009 Jul 7.
引用本文的文献
1
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party.
Hemasphere. 2025 Aug 15;9(8):e70184. doi: 10.1002/hem3.70184. eCollection 2025 Aug.
2
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up.
Hemasphere. 2025 May 7;9(5):e70128. doi: 10.1002/hem3.70128. eCollection 2025 May.
3
Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data.
Front Oncol. 2024 Jul 31;14:1362367. doi: 10.3389/fonc.2024.1362367. eCollection 2024.
4
Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.
Haematologica. 2023 Dec 1;108(12):3244-3260. doi: 10.3324/haematol.2023.282717.
5
A Rare Case of Aggressive Disseminated Nasal-Type Epstein-Barr Virus-Positive Extranodal Natural Killer/T-Cell Lymphoma with Bone Marrow Involvement.
Am J Case Rep. 2023 Jun 18;24:e939286. doi: 10.12659/AJCR.939286.
6
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.
Leukemia. 2023 Jul;37(7):1511-1520. doi: 10.1038/s41375-023-01924-x. Epub 2023 May 8.
7
EBV and Lymphomagenesis.
Cancers (Basel). 2023 Apr 4;15(7):2133. doi: 10.3390/cancers15072133.
8
How we treat NK/T-cell lymphomas.
J Hematol Oncol. 2022 Jun 3;15(1):74. doi: 10.1186/s13045-022-01293-5.
9
Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions.
J Clin Med. 2022 May 10;11(10):2699. doi: 10.3390/jcm11102699.
10
Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies.
Cancers (Basel). 2022 Jan 25;14(3):597. doi: 10.3390/cancers14030597.
本文引用的文献
1
Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell Lymphoma.
N Engl J Med. 2016 Oct 13;375(15):1501-1502. doi: 10.1056/NEJMc1605684.
2
Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Expert Rev Hematol. 2016 Sep;9(9):861-71. doi: 10.1080/17474086.2016.1206465. Epub 2016 Jul 8.
3
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
Lancet Haematol. 2015 Feb;2(2):e66-74. doi: 10.1016/S2352-3026(15)00002-2. Epub 2015 Jan 28.
4
How I treat NK/T-cell lymphomas.
Blood. 2013 Jun 20;121(25):4997-5005. doi: 10.1182/blood-2013-01-453233. Epub 2013 May 7.
5
Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.
Cancer Discov. 2012 Jul;2(7):591-7. doi: 10.1158/2159-8290.CD-12-0028. Epub 2012 Jun 15.
6
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Int J Hematol. 2010 Dec;92(5):697-701. doi: 10.1007/s12185-010-0726-2. Epub 2010 Dec 1.
7
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
Leukemia. 2011 Feb;25(2):348-58. doi: 10.1038/leu.2010.255. Epub 2010 Nov 5.
8
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.
Blood. 2009 Apr 23;113(17):3931-7. doi: 10.1182/blood-2008-10-185256. Epub 2008 Nov 24.
9
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.
Br J Haematol. 2005 Aug;130(4):561-7. doi: 10.1111/j.1365-2141.2005.05651.x.
Zotero 插件